Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
Minimising immunotherapy’s potentially harmful side effects
Minimising immunotherapy’s potentially harmful side effects
Supercharging CAR-T cells for cancer treatment
Supercharging CAR-T cells for cancer treatment
Researchers uncover on/off switch for breast cancer metastasis
Researchers uncover on/off switch for breast cancer metastasis
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk...
Paradoxical role of white blood cells in breast cancer spread
Paradoxical role of white blood cells in breast cancer spread
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk...
ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial
ASH 2023: Third-generation anti-CD19 CAR T-cells demonstrate efficacy without neurotoxicity in B-cell lymphoma...
ASH 2023: Bispecific antibody drives myeloma precursor condition to undetectable levels in phase II trial
ASH 2023: Bispecific antibody drives myeloma precursor condition to undetectable levels in phase II trial
Can we crack this cancer’s immune response?
Can we crack this cancer’s immune response?
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation